News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
634,102 Results
Type
Article (60762)
Company Profile (80)
Press Release (573260)
Section
Business (173456)
Career Advice (2714)
Deals (32392)
Drug Delivery (91)
Drug Development (76738)
Employer Resources (148)
FDA (14858)
Job Trends (13842)
News (304478)
Policy (28885)
Tag
Academia (2869)
Alliances (42920)
Alzheimer's disease (1190)
Approvals (14808)
Artificial intelligence (147)
Bankruptcy (280)
Best Places to Work (10794)
Breast cancer (180)
Cancer (1280)
Cardiovascular disease (99)
Career advice (2295)
CAR-T (89)
Cell therapy (273)
Clinical research (61178)
Collaboration (424)
Compensation (151)
COVID-19 (2522)
C-suite (119)
Data (1335)
Diabetes (147)
Diagnostics (5953)
Earnings (58560)
Employer resources (131)
Events (92224)
Executive appointments (377)
FDA (15481)
Funding (398)
Gene therapy (186)
GLP-1 (554)
Government (4385)
Healthcare (18094)
Infectious disease (2602)
Inflammatory bowel disease (110)
Interviews (522)
IPO (14625)
Job creations (3411)
Job search strategy (1936)
Layoffs (444)
Legal (6393)
Lung cancer (177)
Lymphoma (88)
Manufacturing (175)
Medical device (12500)
Medtech (12505)
Mergers & acquisitions (17945)
Metabolic disorders (391)
Neuroscience (1482)
NextGen Class of 2024 (6366)
Non-profit (4304)
Northern California (1474)
Obesity (218)
Opinion (206)
Patents (112)
People (58610)
Phase I (19211)
Phase II (27004)
Phase III (19720)
Pipeline (474)
Postmarket research (2471)
Preclinical (8210)
Radiopharmaceuticals (241)
Rare diseases (241)
Real estate (5970)
Regulatory (19461)
Research institute (2384)
Resumes & cover letters (405)
Southern California (1301)
Startups (3329)
United States (13353)
Vaccines (542)
Weight loss (151)
Date
Today (29)
Last 7 days (646)
Last 30 days (2280)
Last 365 days (32226)
2024 (31505)
2023 (36339)
2022 (46625)
2021 (51584)
2020 (50732)
2019 (44786)
2018 (34063)
2017 (30737)
2016 (30076)
2015 (35472)
2014 (28406)
2013 (24976)
2012 (26227)
2011 (26476)
2010 (24975)
Location
Africa (865)
Arizona (137)
Asia (37729)
Australia (7261)
California (3284)
Canada (1282)
China (266)
Colorado (158)
Connecticut (161)
Europe (87047)
Florida (477)
Georgia (126)
Illinois (382)
Indiana (194)
Maryland (571)
Massachusetts (2450)
Michigan (170)
Minnesota (238)
New Jersey (998)
New York (948)
North Carolina (734)
Northern California (1474)
Ohio (133)
Pennsylvania (802)
South America (1171)
Southern California (1301)
Texas (493)
Utah (101)
Washington State (353)
634,102 Results for "university of melbourne".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Colossal Foundation Donates $1.5M USD to the University of Melbourne to Support Avian Conservation
November 20, 2024
·
5 min read
Business
David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board Chair
The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability
June 7, 2024
·
8 min read
ONO Enters into a University-Wide, Research Alliance Agreement with Harvard University
Ono Pharmaceutical Co., Ltd. announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University aiming at validating novel therapeutic targets.
March 11, 2024
·
3 min read
Layoffs
Astellas Cuts 24 Universal Cells Roles in Seattle, Transfers 12 to Japan
Astellas is opening a second location of Universal Cells, its wholly owned subsidiary, at a research campus in Japan and transferring 12 roles from Universal’s Seattle location.
October 10, 2024
·
1 min read
·
Angela Gabriel
Lone Star Bio
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
Scientists from Colossal Biosciences, the world’s first de-extinction company, and the University of Melbourne announce a major step forward in the effort to save Australia’s endangered northern quoll from the invasive cane toad.
May 8, 2024
·
9 min read
Propanc Biopharma Targets Site of First-In-Human Study for PRP at the Peter Mac Cancer Center, Melbourne, Australia
Propanc Biopharma, Inc. today announced that the Company will target the Peter Mac Cancer Center in Melbourne, Australia, as the site for the First-In-Human (FIH) study for PRP in patients with advanced solid tumors.
August 15, 2023
·
5 min read
Colossal and U Melbourne Hope to Make Thylacine Lore Reality with CRISPR
Working to undo the sins of the past, Colossal Biosciences and the University of Melbourne are attempting to bring back the Tasmanian tiger in a project that could have big implications for human health.
November 3, 2022
·
5 min read
·
Abbey Glasure
BioMidwest
University of Cincinnati Cancer Center Launches Nation’s Most Comprehensive Blood Cancer Healing Center
The University of Cincinnati Cancer Center inaugurated its state-of-the-art Blood Cancer Healing Center, revolutionizing blood cancer care in the United States.
June 24, 2024
·
4 min read
Pharm Country
PCI Pharma Services Announces New Sterile Fill-Finish Capabilities Now Available in Melbourne and San Diego
PCI Pharma Services, a leading global contract development and manufacturing organization, announced that three new state-of-the-art automated sterile fill-finish machines at its San Diego and Melbourne facilities are now fully operational.
April 18, 2023
·
4 min read
Immuron CEO Steven Lydeamore to present at Peak Sky High
Immuron Limited, an Australian based and globally integrated biopharmaceutical company, is pleased to advise our Chief Executive Officer Steven Lydeamore will be presenting at Peak Asset Management’s Peak Sky High luncheon in Melbourne on June 1, 2024.
May 31, 2024
·
6 min read
1 of 63,411
Next
